Some of the shocking statistic I found from the
http://the-scientist.com/ on personalized medicine as follows:
- FDA recommends that doctors genotype patients before precribing more than 70 commonly-sed medication for specific genetic biomarkers
- Although 98% of the physicians agrees that genotype their patients might be useful to determine their drug response, only 10% believed they were adequately informed about how to test their patients for biomarkers that may predict the safety and/or efficacy of a particular drug, and
- New biomarkers are identified each day
Question (s) that flashes to my mind now (at the point of writing this entry)
- What is the percentage of patients we have so far gains benefits from personalized medicine based on genotyping?
- How long does it normally take for the information to transfers from research laboratory (s) to clinical laboratory (s)? And how long again does the physician will take to really appreciate the newly discovered biomarker (s) or assay?
- And, how many patient (s) who is really aware and confident of the benefits of personalized medicine?
- Of course not to mention of how many percent of physicians can truely and effectively explain the concept (s), benefit (s) and importance of personalized medicine in a way that the patients can truly understand?
No comments:
Post a Comment